The program leverages a comprehensive utilization management (UM) solution to shift utilization to the lower-cost biosimilar versions of infliximab, which is used to treat autoimmune conditions ...

A comprehensive utilization index identifies industry-wide over-utilization and common culprits. The Change Healthcare 2021 Laboratory Ordering Utilization Index is based on an internal analysis ...

Discover how CCUS-EOR technology can enhance oil recovery while reducing carbon emissions. A new study in Engineering ...

Upon its approval in 2017, Novartis priced tisa-cel at $475,000 – a number that many healthcare systems and payers balked at initially – and in 2023 the price increased to $508,250.

Post this on X (formerly Twitter): .@jfrog unveils new integration with @datadoghq for greater cloud-native app utilization visibility and #security. Learn more: https://jfrog.co/4bFcpCL # ...

New research indicates comprehensiveness in primary care could be just as significant as care access and coordination. Patients who receive comprehensive primary care have lower Medicare ...